Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees

This article has 1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

The drastic rise in the number of cases in Maharashtra, India has created a matter of concern for public health experts. Twelve isolates of VUI lineage B.1.617 were propagated in VeroCCL81 cells and characterized. Convalescent sera of the COVID-19 cases and recipients of BBV152 (Covaxin) were able to neutralize VUI B.1.617.

Related articles

Related articles are currently not available for this article.